Daicel OverviewDaicel's common stock is $36B.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2026), DACHF shows a common stock of $36B. That compares with $36B in the prior-year period — down 0.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DACHF's common stock is now $36B (was $36B) — a 0.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Daicel is outperforming or lagging.
Tracking DACHF's common stock over time shows whether Daicel is scaling, shrinking, or reshaping that part of the business. The current reading is $36B That compares with $36B in the prior-year period — down 0.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Daicel's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $36B) with ownership activity and broader fundamentals.
